Unknown

Dataset Information

0

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

ABSTRACT:

SUBMITTER: Di Noia V 

PROVIDER: S-EPMC9548024 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

Di Noia Vincenzo V   Pimpinelli Fulvia F   Renna Davide D   Campo Flaminia F   Cosimati Antonella A   Torchia Andrea A   Marcozzi Benedetta B   Massacci Alice A   Pallocca Matteo M   Pellini Raul R   Morrone Aldo A   Cognetti Francesco F  

European journal of cancer (Oxford, England : 1990) 20221009

Similar Datasets

Unknown Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer.
| S-EPMC8861182 | biostudies-literature
Unknown Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment.
| S-EPMC9341169 | biostudies-literature
Unknown Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.
| S-EPMC9305380 | biostudies-literature
Unknown The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose.
| S-EPMC10078898 | biostudies-literature
Unknown Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
| S-EPMC9501772 | biostudies-literature
Unknown Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.
| S-EPMC9584759 | biostudies-literature
Unknown Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis.
| S-EPMC9024432 | biostudies-literature
Unknown Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.
| S-EPMC8844396 | biostudies-literature
Unknown LONGITUDINAL AGE DIFFERENCES IN HUMORAL RESPONSES TO THE BNT162b2 VACCINE IN THE ELDERLY ARE LOST AFTER THE THIRD DOSE.
| S-EPMC9729577 | biostudies-literature
Unknown Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases.
| S-EPMC11926591 | biostudies-literature